A panel investigated the case of J&J vaccine trial participant who suffered a stroke and said it was unrelated to the vaccine, a media report says.
John Gallo, BNP Paribas head of global markets, has some advice for those anxiously awaiting the end of the recession born of the coronavirus pandemic: Hunker down.
The earliest the economy might return to a pre-COVID level? According to Gallo, it’s mi…
Global packaging solutions company Sonoco Products Co (NYSE: SON) stands to benefit from near-term catalysts in 2021, but it’s hard to justify buying the stock at today’s levels, according to BofA Securities.
Latest Ratings for SON
Nearly three months after commencing the late-stage study of its coronavirus vaccine candidate — mRNA-1273 — and a scare over a slowing enrollment rate, Moderna Inc (NASDAQ: MRNA) said it has completed enrollment in its COVE study.
Brazilian newspaper O Globo reported that a participant in a Phase 3 trial for a COVID-19 vaccine has died.
A novel and controversial vaccine trial for covid-19 is officially set to begin in the UK next January. On Tuesday, researchers from the Imperial College London and elsewhere announced that they plan to conduct a human challenge trial that will involve…
House Speaker Nancy Pelosi and Treasury Secretary Steven Mnuchin are said to have narrowed some of their differences on a coronavirus aid package; Netflix and Lockheed report earnings; Intel sells its NAND memory chip business.
Coronavirus vaccine developer Moderna Inc (NASDAQ: MRNA) is close to achieving 100% enrollment in its Phase 3 COVE study.